AKT1 and breast cancer: BC subtype–specific subanalyses showed a differential impact of TP53mut (Figs 2A-2H; Data Supplement, Figs S2A-S2D) and PI3K/AKT pathway alterations (Figs 3A-3H; Data Supplement, Figs S3A-S3D) on survival.